نتائج البحث - "Kates, Ronald"

1

دورية أكاديمية

Immune Markers and Tumor-Related Processes Predict Neoadjuvant Therapy Response in the WSG-ADAPT HER2-Positive/Hormone Receptor-Positive Trial in Early Breast Cancer

مصطلحات موضوعية: biomarkers, breast cancer, HER2-positive, hormone receptor-positive, immune markers, info:eu-repo/classification/ddc/610, ddc:610

العلاقة: 4884

الإتاحة: https://ul.qucosa.de/id/qucosa%3A84985Test
https://ul.qucosa.de/api/qucosa%3A84985/attachment/ATT-0Test/

النص الكامل

2

مؤتمر

Abstract OT3-33-01: Prospective, Multi-Center, Artificial Intelligence Study for Early Prediction of Serious Events under Treatment Is Now Open for Recruitment in Breast Cancer - OMCAT Trial in Progress

المؤلفون: Schinköthe, Timo, Tonk, Christian, Kates, Ronald, Küemmel, Sherko, Cardoso, Fatima, Harbeck, Nadia, Staib, Peter, Schmidt, Annette

المصدر: Schinköthe, Timo; Tonk, Christian; Kates, Ronald; Küemmel, Sherko; Cardoso, Fatima; Harbeck, Nadia; Staib, Peter; Schmidt, Annette: Abstract OT3-33-01: Prospective, Multi-Center, Artificial Intelligence Study for Early Prediction of Serious Events under Treatment Is Now Open for Recruitment in Breast Cancer - OMCAT Trial in Progress. San Antonio Breast Cancer Symposium 2022, 2023

العلاقة: http://athene-forschung.unibw.de/node?id=146200Test; https://doi.org/10.1158/1538-7445.SABCS22-OT3-33-01Test

الإتاحة: https://doi.org/10.1158/1538-7445.SABCS22-OT3-33-01Test
http://athene-forschung.unibw.de/node?id=146200Test

View record in BASE

3

مؤتمر

Abstract P6-03-08: Trained Artificial Intelligence (AI) for Predicting Treatment Termination Based on Patient Observations in Advanced Breast Cancer

المؤلفون: Schinköthe, Timo, Kates, Ronald, Sprecher, Benedikt, Meyer, Silja, Tonk, Christian, Harbeck, Nadia, Schmidt, Annette

المصدر: Schinköthe, Timo; Kates, Ronald; Sprecher, Benedikt; Meyer, Silja; Tonk, Christian; Harbeck, Nadia; Schmidt, Annette: Abstract P6-03-08: Trained Artificial Intelligence (AI) for Predicting Treatment Termination Based on Patient Observations in Advanced Breast Cancer. San Antonio Breast Cancer Symposium 2022, 2023

العلاقة: http://athene-forschung.unibw.de/node?id=146202Test; https://doi.org/10.1158/1538-7445.SABCS22-P6-03-08Test

الإتاحة: https://doi.org/10.1158/1538-7445.SABCS22-P6-03-08Test
http://athene-forschung.unibw.de/node?id=146202Test

View record in BASE

4

دورية أكاديمية

PRECYCLE: multicenter, randomized phase IV intergroup trial to evaluate the impact of eHealth-based patient-reported outcome (PRO) assessment on quality of life in patients with hormone receptor positive, HER2 negative locally advanced or metastatic breast cancer treated with palbociclib and an aromatase inhibitor or palbociclib and fulvestrant

المصدر: Degenhardt, Tom; Fasching, Peter A; Lüftner, Diana; Müller, Volkmar; Thomssen, Christoph; Schem, Christian; Witzel, Isabell; Decker, Thomas; Tesch, Hans; Kümmel, Sherko; Uleer, Christoph; Wuerstlein, Rachel; Hoffmann, Oliver; Warm, Mathias; Marschner, Norbert; Schinköthe, Timo; Kates, Ronald E; Schumacher, Johannes; Otremba, Burkhard; Zaiss, Matthias; Harbeck, Nadia; Schmidt, Marcus; PreCycle Investigators (2023). PRECYCLE: multicenter, randomized phase IV intergroup trial to evaluate the impact of eHealth-based patient-reported outcome (PRO) assessment on quality of life in patients with hormone receptor positive, HER2 negative locally advanced or metastatic breast cancer treated with palbociclib and an aromatase inhibitor or palbociclib and fulvestrant. Trials, 24(1):338.

مصطلحات موضوعية: Clinic for Gynecology, 610 Medicine & health, Pharmacology (medical), Medicine (miscellaneous)

وصف الملف: application/pdf

العلاقة: https://www.zora.uzh.ch/id/eprint/256293/1/ZORA_s13063_023_07306_z.pdfTest; info:pmid/37198674; urn:issn:1745-6215

الإتاحة: https://doi.org/10.5167/uzh-25629310.1186/s13063-023-07306-zTest
https://www.zora.uzh.ch/id/eprint/256293Test/
https://www.zora.uzh.ch/id/eprint/256293/1/ZORA_s13063_023_07306_z.pdfTest

View record in BASE

النص الكامل

5

دورية أكاديمية

The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer : a pooled analysis of the randomised clinical trials PlanB and SUCCESS C

مصطلحات موضوعية: DDC 610 / Medicine & health, Breast, Cancer, Breast neoplasms, Randomized controlled trial

وصف الملف: application/pdf

العلاقة: https://static-content.springer.com/esm/art%3A10.1038%2Fs41416-021-01690-6/MediaObjects/41416_2021_1690_MOESM2_ESM.pptxTest; https://static-content.springer.com/esm/art%3A10.1038%2Fs41416-021-01690-6/MediaObjects/41416_2021_1690_MOESM3_ESM.docxTest; https://static-content.springer.com/esm/art%3A10.1038%2Fs41416-021-01690-6/MediaObjects/41416_2021_1690_MOESM4_ESM.pdfTest; https://static-content.springer.com/esm/art%3A10.1038%2Fs41416-021-01690-6/MediaObjects/41416_2021_1690_MOESM5_ESM.docTest; http://dx.doi.org/10.18725/OPARU-47449Test; https://oparu.uni-ulm.de/xmlui/123456789/47525Test; http://nbn-resolving.de/urn:nbn:de:bsz:289-oparu-47525-7Test

الإتاحة: https://doi.org/10.18725/OPARU-47449Test
https://oparu.uni-ulm.de/xmlui/123456789/47525Test
http://nbn-resolving.de/urn:nbn:de:bsz:289-oparu-47525-7Test

View record in BASE

6

دورية أكاديمية

Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR− Trial

المصدر: Clinical cancer research 29(4), 805-814 (2023). doi:10.1158/1078-0432.CCR-22-1587

جغرافية الموضوع: DE

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/pmid:36441798; info:eu-repo/semantics/altIdentifier/wos/WOS:000964433700001; info:eu-repo/semantics/altIdentifier/issn/1078-0432; info:eu-repo/semantics/altIdentifier/issn/1557-3265; https://publications.rwth-aachen.de/record/945835Test; https://publications.rwth-aachen.de/search?p=id:%22RWTH-CONV-250791%22Test

الإتاحة: https://doi.org/10.1158/1078-0432.CCR-22-1587Test
https://doi.org/10.18154/RWTH-CONV-250791Test
https://publications.rwth-aachen.de/record/945835Test
https://publications.rwth-aachen.de/search?p=id:%22RWTH-CONV-250791%22Test

View record in BASE